A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
Background: Biliary tract carcinoma (BTC) is rare in the West, but not uncommon in Asia and is a highly fatal malignancy. VEGF expression is related with poor outcome in patients with BTC. Therefore, we conducted a phase II study to evaluate the efficacy and safety of sunitinib as second-line treatm...
Saved in:
Main Authors: | Yi J., Thongprasert S., Lee J., Doval D., Park S., Park J., Park Y., Kang W., Lim H. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84655161964&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/42930 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
by: Jun Ho Yi, et al.
Published: (2018) -
Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
by: Thongprasert S., et al.
Published: (2014) -
Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
by: S. Thongprasert, et al.
Published: (2018) -
PRIMARY CARCINOMA OF THE LIVER AND BILIARY TRACT
by: SHANMUGARATNAM K
Published: (2020) -
The international sinonasal microbiome study: A multicentre, multinational characterization of sinonasal bacterial ecology
by: Sathish Paramasivan, et al.
Published: (2020)